Current
19.4×
5-Year Average
23.8×
All-Time High
61.7×
All-Time Low
9.8×
P/FCF Ratio daily chart for Medtronic (MDT)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for Medtronic (MDT) from 2002 to 2026
| 2026 | $106.80B | $5.43B | 19.7× | — | |
| 2025 | — | $5.18B | — | — | |
| 2024 | — | $5.20B | — | — | |
| 2023 | $120.64B | $4.58B | 26.3× | +3.0× | |
| 2022 | $139.59B | $5.98B | 23.4× | -12.8× | |
| 2021 | $176.39B | $4.88B | 36.1× | +14.4× | |
| 2020 | $130.88B | $6.02B | 21.7× | +1.5× | |
| 2019 | $119.06B | $5.87B | 20.3× | -9.8× | |
| 2018 | $108.57B | $3.62B | 30.0× | +9.6× | |
| 2017 | $114.64B | $5.63B | 20.4× | -6.2× | |
| 2016 | $110.87B | $4.17B | 26.6× | +2.1× | |
| 2015 | $105.89B | $4.33B | 24.4× | +11.6× | |
| 2014 | $58.82B | $4.56B | 12.9× | +2.2× | |
| 2013 | $47.34B | $4.43B | 10.7× | +0.7× | |
| 2012 | $39.73B | $3.97B | 10.0× | -4.0× | |
| 2011 | $44.68B | $3.19B | 14.0× | +0.2× | |
| 2010 | $48.07B | $3.50B | 13.8× | +2.7× | |
| 2009 | $35.68B | $3.21B | 11.1× | -7.9× | |
| 2008 | $54.72B | $2.88B | 19.0× | -7.6× | |
| 2007 | $60.68B | $2.29B | 26.6× | -35.1× | |
| 2006 | $59.43B | $963.20M | 61.7× | +34.8× | |
| 2005 | $63.67B | $2.37B | 26.9× | +1.7× | |
| 2004 | $61.08B | $2.42B | 25.2× | -9.0× | |
| 2003 | $58.17B | $1.70B | 34.3× | -10.7× | |
| 2002 | $54.18B | $1.20B | 45.0× | — |
- 202619.7×
- 2025—
- 2024—
- 202326.3×
- 202223.4×
- 202136.1×
- 202021.7×
- 201920.3×
- 201830.0×
- 201720.4×
- 201626.6×
- 201524.4×
- 201412.9×
- 201310.7×
- 201210.0×
- 201114.0×
- 201013.8×
- 200911.1×
- 200819.0×
- 200726.6×
- 200661.7×
- 200526.9×
- 200425.2×
- 200334.3×
- 200245.0×
About P/FCF Ratio at Medtronic (MDT)
Medtronic (MDT) P/FCF ratio is 19.4× as of June 5, 2026. The 5-year average is 23.8×. The sector median currently stands at 19.8×. The current ratio is at the 6th percentile of its own 10-year history.
Medtronic (MDT) historical P/FCF ratio has ranged from a low of 9.8× (2012) to a high of 61.7× (2006) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Medtronic P/FCF Ratio by Year
Medtronic P/FCF Ratio 2026: 19.7×
Medtronic (MDT) P/FCF ratio in 2026 was 19.7×, contracted from 26.3× the prior year.
Medtronic P/FCF Ratio 2023: 26.3×
Medtronic (MDT) P/FCF ratio in 2023 was 26.3×, expanded from 23.4× the prior year.
Medtronic P/FCF Ratio 2022: 23.4×
Medtronic (MDT) P/FCF ratio in 2022 was 23.4×, contracted from 36.1× the prior year.
Medtronic P/FCF Ratio 2021: 36.1×
Medtronic (MDT) P/FCF ratio in 2021 was 36.1×, expanded from 21.7× the prior year.
Medtronic P/FCF Ratio 2020: 21.7×
Medtronic (MDT) P/FCF ratio in 2020 was 21.7×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Medtronic (MDT), ranked by P/FCF ratio.
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric